# FMED holdings and overlap

Fidelity Disruptive Medicine ETF (FMED) holds 68 positions in its SEC Form N-PORT for the period ended 2026-05-31, filed 2026-07-24. Its three largest are Ucb SA (UCB.BE) at 4.73%, LifeStance Health Group (LFST) at 4.27% and Danaher (DHR) at 3.42%, and its ten largest make up 31.4% of the fund.

Fidelity Disruptive Medicine ETF, Health Care, Fidelity.

Canonical page: https://tickerinside.com/etf/fmed/
Holdings from FMED's SEC Form N-PORT for the period ended 2026-05-31, filed 2026-07-24.
Licence: CC BY 4.0, attribution to TickerInside. Measurements, not investment advice.

## Largest positions, SEC Form N-PORT for the period ended 2026-05-31

| Rank | Ticker | Company | Weight |
| --- | --- | --- | --- |
| 1 | UCB.BE | Ucb SA | 4.73% |
| 2 | LFST | LifeStance Health Group | 4.27% |
| 3 | [DHR](https://tickerinside.com/stock/dhr/) | Danaher | 3.42% |
| 4 | TXG | 10x Genomics | 3.11% |
| 5 | [ISRG](https://tickerinside.com/stock/isrg/) | Intuitive Surgical | 2.92% |
| 6 | COGT | Cogent Biosciences | 2.85% |
| 7 | ALNY | Alnylam Pharmaceuticals | 2.79% |
| 8 | ARGX | Argenx SE | 2.78% |
| 9 | LEGN | Legend Biotech Corp | 2.29% |
| 10 | [UNH](https://tickerinside.com/stock/unh/) | UnitedHealth Group | 2.25% |
| 11 | TECH | Bio-Techne | 2.24% |
| 12 | ASND | Ascendis Pharma A/S | 2.11% |
| 13 | [EW](https://tickerinside.com/stock/ew/) | Edwards Lifesciences | 2.11% |
| 14 | MRNA | Moderna | 2.11% |
| 15 | KYMR | Kymera Therapeutics | 1.99% |
| 16 | XENE | Xenon Pharmaceuticals | 1.92% |
| 17 | HTFL | HeartFlow Inc | 1.89% |
| 18 | DIM.FR | Sartorius Stedim Biotech | 1.84% |
| 19 | INSM | Insmed | 1.79% |
| 20 | [VEEV](https://tickerinside.com/stock/veev/) | Veeva Systems | 1.78% |
| 21 | PCVX | Vaxcyte | 1.76% |
| 22 | RVMD | Revolution Medicines | 1.73% |
| 23 | CAI | Caris Life Sciences Inc | 1.71% |
| 24 | CRNX |  | 1.65% |
| 25 | AXSM | Axsome Therapeutics | 1.57% |

All 68 positions with weights: https://tickerinside.com/api/v1/fund/fmed.json

Category: Health Care, set by TickerInside from the ETF's own latest file. In its file of 2026-05-31, 100% of its stocks whose sector is known are health care companies, each in the sector the site gives that company. How categories are set: https://tickerinside.com/etf/category/

## How is FMED split by sector and country?

In its SEC Form N-PORT for the period ended 2026-05-31, filed 2026-07-24, FMED is 99.7% health care by sector, with none of it in mega-cap tech or in the ten largest US companies by market value. By country, 82.8% of FMED is in the United States, 7.5% in Belgium, 2.3% in China and 2.1% in Denmark.

| Sector | Weight |
| --- | --- |
| Health care | 99.7% |

| Country | Weight |
| --- | --- |
| United States | 82.8% |
| Belgium | 7.5% |
| China | 2.3% |
| Denmark | 2.1% |
| Canada | 1.9% |
| France | 1.8% |
| Switzerland | 1.2% |

How these are measured: https://tickerinside.com/how-the-numbers-are-produced/#sectors


## What did FMED hold in its SEC reports since 2023?

In FMED's SEC filings, its largest position went from Boston Scientific (BSX) at 4.75% on 2023-08-31 to Ucb SA (UCB.BE) at 4.73% on 2026-05-31, across 12 quarterly reports.

| Report for | Positions | Largest position | Ten largest |
| --- | --- | --- | --- |
| 2023-08-31 | 69 | BSX 4.75% | 34.9% |
| 2023-11-30 | 67 | BSX 5.53% | 36.5% |
| 2024-11-30 | 59 | BSX 6.34% | 38.9% |
| 2025-11-30 | 66 | EXAS 5.00% | 37.5% |
| 2026-05-31 | 68 | UCB.BE 4.73% | 31.4% |

The first report, then the last of each year, of the 12 reports FMED filed on SEC Form N-PORT from 2023-08-31 to 2026-05-31; companies are keyed by their ticker today. Every position of every report: https://tickerinside.com/api/v1/quarterly/fmed.json; at any date: https://tickerinside.com/api/v1/history/fmed/{date}.json. How these are read: https://tickerinside.com/how-the-numbers-are-produced/#sec-history
## Key figures

| Measure | Value |
| --- | --- |
| Expense ratio, SEC filing 2026-09-24 | 0.5% |
| Positions, N-PORT 2026-05-31 | 68 |
| Weight in the ten largest, N-PORT 2026-05-31 | 31.4% |

## What does FMED share with other ETFs?

| ETF | Overlap by weight | Of FMED held there | Of that ETF in FMED | Companies in both |
| --- | --- | --- | --- | --- |
| IBB | 21.4% | 49.5% | 30.4% | 37 |
| RSPH | 20.7% | 25.4% | 24.3% | 14 |
| IBBQ | 19.0% | 47.9% | 25.7% | 36 |
| IYH | 18.8% | 42.0% | 38.8% | 25 |
| GNOM | 18.7% | 21.5% | 44.0% | 11 |
| BMED | 18.6% | 29.6% | 31.5% | 15 |
| XBI | 17.9% | 28.0% | 23.2% | 23 |
| VHT | 17.8% | 77.9% | 35.7% | 56 |
| XLV | 15.7% | 25.4% | 36.4% | 14 |
| PTH | 15.6% | 19.3% | 30.1% | 11 |
| IXJ | 14.3% | 33.2% | 27.7% | 17 |
| BBH | 14.2% | 14.9% | 26.6% | 7 |


FMED's holdings are from its SEC Form N-PORT for the period ended 2026-05-31, filed 2026-07-24. VHT's holdings are from its SEC Form N-PORT for the period ended 2026-05-31, filed 2026-07-29. BBH's holdings are from its SEC Form N-PORT for the period ended 2026-06-30, filed 2026-08-26. The other ETFs' holdings are from their issuers' latest files.

Method: https://tickerinside.com/how-the-numbers-are-produced/

## Cite this page

TickerInside, Fidelity Disruptive Medicine ETF (FMED), holdings from SEC Form N-PORT for the period ended 2026-05-31, filed 2026-07-24, https://tickerinside.com/etf/fmed/, CC BY 4.0

    <a href="https://tickerinside.com/etf/fmed/">TickerInside</a> (https://tickerinside.com/etf/fmed/)